This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Toxinvent Ou. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations in Cancer Treatment by Ago Rinken
Introduction
Ago Rinken is a notable inventor based in Tartu, Estonia. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. His work focuses on antibody-drug conjugates, which are crucial in the fight against cancer.
Latest Patents
Ago Rinken holds a patent for "Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment." This invention relates to novel anthracycline derivatives that include two oxazolidine cycles. The patent also covers the preparation of these anthracycline derivatives. Furthermore, it discusses the use of antibody-drug conjugates (ADCs) that incorporate these novel derivatives in the prevention and treatment of cancer. He has 1 patent to his name.
Career Highlights
Throughout his career, Ago Rinken has worked with various companies, including Toxinvent OÜ and Tbd-Biodiscovery. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative cancer therapies.
Collaborations
He has collaborated with notable coworkers such as Uno Mäeorg and Olga Tsubrik. Their combined expertise has further enhanced the research and development efforts in the field of cancer treatment.
Conclusion
Ago Rinken's contributions to cancer treatment through his innovative patents and collaborations highlight the importance of research in developing effective therapies. His work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile